Formulations and NDDS
The drug delivery technology market is expected to reach USD 1,504.7 Billion by 2020 from USD 1,048.1 Billion in 2016, growing at a CAGR of 7.5% from 2015 to 2020. The global market for Novel Drug Delivery Systems (NDDS) is expected to hit USD 320 billion by the year 2021. With the rising number of patients suffering from different types of cancer, favorable reimbursement scenario in US, improved and advanced healthcare infrastructure have driven North America to become the leading regional segment in the global NDDS in cancer therapy market. Among the NDDS technologies Embolization of Particles, Selective Internal Radiation Therapy (SIRT), Holmium-based Microspheres, Liquid Embolics and Nanoparticles are gaining importance from market point of view.
- Pre-Formulation & Formulation Aspects
- Nanoparticulate Drug Delivery Systems
- Smart Drug Delivery Systems
- Medical Devices for Drug Delivery
- 2D & 3D Printing in Drug Delivery
- Global Drug Delivery Policy
Related Conference of Formulations and NDDS
Formulations and NDDS Conference Speakers
Recommended Sessions
- Analytical strategies for pharmaceutical products
- API: Active Pharmaceutical Ingredients
- Clinical trials and Pharmacovigilance
- Drug discovery and NCEs
- Formulations and NDDS
- Pharma Market Research
- Pharmaceutical Manufacturing,Scale Up and Tech transfer
- Pharmaceutical Packaging and Logistics
- Pharmacoeconomics
- QC & QA: Quality control and Quality assurance
- Quality by design(QbD) approach
- Regulatory Authority Compliance